Natera share price today
(NASDAQ: NTRA)

Name: Natera Share Price Today (NASDAQ: NTRA) - Natera Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Natera share price is $171.93 & ₹14,854.75 as on 23 Jan 2025, 2.30 'hrs' IST

$171.93

▲

4.47

(2.67%)

Market is closed - opens 8 PM, 23 Jan 2025

View live Natera share price in Dollar and Rupees. Guide to invest in Natera stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Natera, along with analyst recommendations, forecasts, and comprehensive financials.

Natera share price movements

Today's Low: $168.26
Today's High: $173.10
$171.93
2.13%
Downside
Day's Volatility :2.8%
Upside
0.68%
52 Weeks Low: $62.96
52 Weeks High: $183.00
$171.93
63.38%
Downside
52 Weeks Volatility :65.6%
Upside
6.05%

Natera Returns

Period	Natera Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	40.52%	-5.7%	0.0%
6 Months	63.94%	-4.2%	0.0%
1 Year	155.24%	1.7%	0.0%
3 Years	160.03%	10.1%	-11.0%

Natera Key Statistics

in dollars & INR

Previous Close	$167.46
Open	$168.35
Today's High	$173.1
Today's Low	$168.26
Market Capitalization	$22.1B
Today's Volume	$2.0M
52 Week High	$183.0
52 Week Low	$62.96
Revenue TTM	$1.5B
EBITDA	$-214.4M
Earnings Per Share (EPS)	$-1.76
Profit Margin	-14.01%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-25.82%

How to invest in Natera Stock (NTRA) from India?

It is very easy for Indian residents to invest directly in Natera from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Natera stock in both Indian Rupees (INR) and US Dollars (USD). Search for Natera or NTRA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Natera or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Natera shares which would translate to 0.005 fractional shares of Natera as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Natera, in just a few clicks!

Returns in Natera for Indian investors in Rupees

Investment Value

₹1,00,000

Natera investment value today

Current value as on today

₹2,66,002

Returns

₹1,66,002

(+166%)

Returns from Natera Stock

₹1,62,048 (+162.05%)

Dollar Returns

₹3,954 (+3.95%)

Indian investors sentiment towards Natera

4.0%

Period: Oct 24, 2024 to Jan 22, 2025. Change in 30 Days versus previous period

Investment in Natera from India has grown in the last 30 days as on Jan 23, 2025. 4.0% more purchase transactions for Natera in the last 30 days versus the previous period.

-35%

Period: Oct 24, 2024 to Jan 22, 2025. Change in 30 Days versus previous period

Search volume for Natera on INDmoney from India has reduced in the last 30 days as on Jan 23, 2025. -35% less investors are searching Natera in the last 30 days versus the previous period.

Global Institutional Holdings in Natera

Vanguard Group Inc
8.66%
BlackRock Inc
6.24%
JPMorgan Chase & Co
3.51%
Farallon Capital Management, L.L.C.
3.45%
Fred Alger Management, LLC
3.04%
Duquesne Family Office LLC
2.70%

Analyst Recommendation on Natera

Buy

91%Buy

4%Hold

4%Sell

Based on 23 Wall street analysts offering stock ratings for Natera(by analysts ranked 0 to 5 stars)

Based on 23 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Natera

What analysts predicted

Upside of 2.87%

Target:

$176.87

Current:

$171.93

Insights on Natera

Price Movement
In the last 3 months, NTRA stock has moved up by 39.6%
Increasing Revenue
Revenue is up for the last 14 quarters, 142.02M → 439.75M (in $), with an average increase of 8.2% per quarter
Increasing Net Profit
Netprofit is up for the last 8 quarters, -142.57M → -31.59M (in $), with an average increase of 26.2% per quarter

Natera Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$257.7M	↑ 22.15%
Net Income	$-128.2M	↓ 5.99%
Net Profit Margin	-49.74%	↑ 14.88%

	FY19	Y/Y Change
Revenue	$302.3M	↑ 17.34%
Net Income	$-124.8M	↓ 2.6%
Net Profit Margin	-41.29%	↑ 8.45%

	FY20	Y/Y Change
Revenue	$391.0M	↑ 29.33%
Net Income	$-229.7M	↑ 84.05%
Net Profit Margin	-58.76%	↓ 17.47%

	FY21	Y/Y Change
Revenue	$625.5M	↑ 59.97%
Net Income	$-471.7M	↑ 105.32%
Net Profit Margin	-75.42%	↓ 16.66%

	FY22	Y/Y Change
Revenue	$820.2M	↑ 31.13%
Net Income	$-547.8M	↑ 16.13%
Net Profit Margin	-66.79%	↑ 8.63%

	FY23	Y/Y Change
Revenue	$1.1B	↑ 31.99%
Net Income	$-434.8M	↓ 20.63%
Net Profit Margin	-40.16%	↑ 26.63%

	Q2 FY23	Q/Q Change
Revenue	$261.4M	↑ 8.13%
Net Income	$-110.8M	↓ 19.08%
Net Profit Margin	-42.39%	↑ 14.25%

	Q3 FY23	Q/Q Change
Revenue	$268.3M	↑ 2.64%
Net Income	$-109.0M	↓ 1.6%
Net Profit Margin	-40.64%	↑ 1.75%

	Q4 FY23	Q/Q Change
Revenue	$311.1M	↑ 15.95%
Net Income	$-78.0M	↓ 28.43%
Net Profit Margin	-25.08%	↑ 15.56%

	Q1 FY24	Q/Q Change
Revenue	$367.7M	↑ 18.2%
Net Income	$-67.6M	↓ 13.37%
Net Profit Margin	-18.38%	↑ 6.7%

	Q2 FY24	Q/Q Change
Revenue	$413.4M	↑ 12.4%
Net Income	$-37.5M	↓ 44.58%
Net Profit Margin	-9.06%	↑ 9.32%

	Q3 FY24	Q/Q Change
Revenue	$439.8M	↑ 6.39%
Net Income	$-31.6M	↓ 15.67%
Net Profit Margin	-7.18%	↑ 1.88%

	FY18	Y/Y Change
Profit	$91.6M	↑ 28.39%

	FY19	Y/Y Change
Profit	$126.9M	↑ 38.49%

	FY20	Y/Y Change
Profit	$187.4M	↑ 47.71%

	FY21	Y/Y Change
Profit	$307.1M	↑ 63.87%

	FY22	Y/Y Change
Profit	$364.0M	↑ 18.53%

	FY23	Y/Y Change
Profit	$492.7M	↑ 35.38%

	Q2 FY23	Q/Q Change
Profit	$118.3M	↑ 26.3%

	Q3 FY23	Q/Q Change
Profit	$121.0M	↑ 2.32%

	Q4 FY23	Q/Q Change
Profit	$159.9M	↑ 32.12%

	Q1 FY24	Q/Q Change
Profit	$208.6M	↑ 30.49%

	Q2 FY24	Q/Q Change
Profit	$243.2M	↑ 16.57%

	Q3 FY24	Q/Q Change
Profit	$271.7M	↑ 11.75%

	FY18	Y/Y Change
Operating Cash Flow	$-70.6M	↓ 27.08%
Investing Cash Flow	$-5.2M	↓ 137.44%
Financing Cash Flow	$113.7M	↑ 41.5%

	FY19	Y/Y Change
Operating Cash Flow	$-63.4M	↓ 10.11%
Investing Cash Flow	$-266.4M	↑ 5060.88%
Financing Cash Flow	$340.8M	↑ 199.65%

	FY20	Y/Y Change
Operating Cash Flow	$-182.5M	↑ 187.67%
Investing Cash Flow	$-331.5M	↑ 24.44%
Financing Cash Flow	$500.8M	↑ 46.97%

	FY21	Y/Y Change
Operating Cash Flow	$-335.2M	↑ 83.68%
Investing Cash Flow	$-205.2M	↓ 38.09%
Financing Cash Flow	$576.2M	↑ 15.04%

	FY22	Y/Y Change
Operating Cash Flow	$-431.5M	↑ 28.72%
Investing Cash Flow	$330.3M	↓ 260.99%
Financing Cash Flow	$482.6M	↓ 16.24%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-78.4M	↓ 3.1%
Investing Cash Flow	$47.0M	↑ 200.49%
Financing Cash Flow	$9.3M	↑ 304.69%

Natera Technicals Summary

Sell

Neutral

Buy

Natera is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Natera Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Natera Inc	3.12%	63.94%	155.24%	160.03%	373.72%
Agilent Technologies Inc.	13.35%	13.03%	17.56%	10.46%	76.26%
Idexx Laboratories, Inc.	3.43%	-9.21%	-17.85%	-16.48%	54.1%
Thermo Fisher Scientific, Inc.	9.09%	-3.61%	6.12%	-0.48%	73.15%
Danaher Corp.	6.52%	-9.62%	6.78%	-11.83%	51.43%
Iqvia Holdings Inc.	3.3%	-11.45%	-3.38%	-15.6%	30.88%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Natera Inc	NA	NA	0.0	-1.56	-0.26	-0.1	NA	7.08
Agilent Technologies Inc.	34.36	34.36	2.49	5.57	0.25	0.08	0.0	20.53
Idexx Laboratories, Inc.	41.25	41.25	4.41	10.69	0.59	0.23	NA	19.72
Thermo Fisher Scientific, Inc.	35.93	35.93	2.16	21.69	0.13	0.05	0.0	128.08
Danaher Corp.	46.15	46.15	3.18	7.51	0.08	0.04	0.0	71.03
Iqvia Holdings Inc.	26.99	26.99	1.04	11.11	0.22	0.05	NA	38.37

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Natera Inc	Buy	$22.1B	373.72%	NA	-14.01%
Agilent Technologies Inc.	Buy	$43.6B	76.26%	34.36	21.75%
Idexx Laboratories, Inc.	Buy	$35.0B	54.1%	41.25	22.53%
Thermo Fisher Scientific, Inc.	Buy	$219.2B	73.15%	35.93	14.48%
Danaher Corp.	Buy	$176.3B	51.43%	46.15	16.39%
Iqvia Holdings Inc.	Buy	$37.3B	30.88%	26.99	9.17%

Natera Dividend announcements

Natera Earnings
Natera’s price-to-earnings ratio stands at None
Read More

About Natera

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born. The company also provides Signatera, a ctDNA blood test for molecular residual disease assessment and surveillance of disease recurrence in patients previously diagnosed with cancer; Altera, a tissue based comprehensive genomic profiling test; Prospera to assess active rejection in patients who have undergone kidney, heart, and lung transplantation; and Renasight, a kidney gene panel test. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics to validate and launch tests. The company offers products through its direct sales force, as well as through a network of laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was founded in 2003 and is headquartered in Austin, Texas.

Organization	Natera
Employees	3282
CEO	Dr. Matthew Rabinowitz Ph.D.
Industry	Health Technology

Management People of Natera

Name	Title
Dr. Matthew Rabinowitz Ph.D.	Co-Founder & Executive Chairman
Mr. Steven Leonard Chapman	CEO & Director
Mr. Michael B. Brophy M.B.A.	Chief Financial Officer
Mr. Daniel Rabinowitz L.L.M.	Secretary & Chief Legal Officer
Mr. John Fesko	President & Chief Business Officer
Mr. Jonathan Sheena M.Eng.	Co-Founder & Director
Ms. Olesya A. Anisimova CPA	Chief Accounting Officer
Mr. Rishi Kacker	Chief Technology Officer
Mr. Eric A. Evans	Chief Scientific Officer
Mr. Jerry Diffley	Chief Compliance & Privacy Officer

Important FAQs about investing in Natera (NTRA) from India :

What is Natera share price today?

Natera share price today stands at $171.93, Open: $168.35 ; Previous Close: $167.46 ; High: $173.10 ; Low: $168.26 ; 52 Week High: $183.00 ; 52 Week Low: $62.96. The stock opens at $168.35, after a previous close of $167.46. The stock reached a daily high of $173.10 and a low of $168.26, with a 52-week high of $183.00 and a 52-week low of $62.96.

Can Indians buy Natera shares?

Yes, Indians can invest in the Natera (NTRA) from India.

With INDmoney, you can buy Natera at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Natera at zero transaction cost.

How can I buy Natera shares from India?

It is very easy to buy Natera from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Natera be purchased?

Yes, you can buy fractional shares of Natera with INDmoney app.

What are the documents required to start investing in Natera stocks?

To start investing in Natera, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.